0001780605-24-000001.txt : 20241202 0001780605-24-000001.hdr.sgml : 20241202 20241202163527 ACCESSION NUMBER: 0001780605-24-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241202 DATE AS OF CHANGE: 20241202 EFFECTIVENESS DATE: 20241202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gemelli Biotech Corp. CENTRAL INDEX KEY: 0001780605 ORGANIZATION NAME: IRS NUMBER: 481304650 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-448519 FILM NUMBER: 241519568 BUSINESS ADDRESS: STREET 1: 9805 BURGEN AVE. CITY: LOS ANGELES STATE: CA ZIP: 90034 BUSINESS PHONE: (919) 451-0533 MAIL ADDRESS: STREET 1: 9805 BURGEN AVE. CITY: LOS ANGELES STATE: CA ZIP: 90034 D/A 1 primary_doc.xml X0708 D/A LIVE 0001780605 Gemelli Biotech Corp. 2009 Fairview Rd. #6099 Raleigh NC NORTH CAROLINA 27628 (919) 451-0533 DELAWARE None None Corporation true Matthew Mitcho c/o Gemelli Biotech Corp. 2009 Fairview Rd. #6099 Raleigh NC NORTH CAROLINA 27628 Executive Officer Director James Laur c/o Gemelli Biotech Corp. 2009 Fairview Rd. #6099 Raleigh NC NORTH CAROLINA 27628 Director John A. Neczesny c/o Gemelli Biotech Corp. 2009 Fairview Rd. #6099 Raleigh NC NORTH CAROLINA 27628 Director Oded Levy c/o Gemelli Biotech Corp. 2009 Fairview Rd. #6099 Raleigh NC NORTH CAROLINA 27628 Director Ritish Agarwal c/o Gemelli Biotech Corp. 2009 Fairview Rd. #6099 Raleigh NC NORTH CAROLINA 27628 Director Biotechnology Decline to Disclose 06b true 0001780605-22-000001 2021-12-07 true true false 0 23910940 21176893 2734047 Total amount sold includes $5,886,630.10 of cancellation of indebtedness and $15,290,262.98 of new cash. false 128 0 0 0 false Gemelli Biotech Corp. /s/ Matthew Mitcho Matthew Mitcho Chief Executive Officer 2024-12-02